Welcome and introduction (ID 4875)
Defining unmet needs in advanced prostate cancer: The conundrum of the third line (ID 4876)
Available and emerging biomarker-driven targeted treatments in mCRPC (ID 4877)
Advances in imaging-based patient selection (ID 4878)
Live panel discussion: Managing the mCRPC patient in the new era of targeted treatment (ID 4879)
Live Q&A session (ID 4880)